Atrial Fibrillation Trial, Recruiting NCT06552845 Sponsor: China National Center for Cardiovascular Diseases Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06552845
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are willing to take part and are able to sign a consent form
  • People who have been diagnosed with atrial fibrillation (an irregular heartbeat) and whose doctor has recommended a procedure called catheter ablation to treat it

Who may not be able to join:

  • People who have a blood clot in the left side of their heart or in a part of the heart called the left atrial appendage
  • People with severe chronic lung disease, based on specific breathing test results (confirm with trial site)
  • People for whom blood-thinning medication is completely not an option due to medical reasons
  • People who are currently pregnant
  • People who are unable to have a specific type of MRI scan called LGE-MRI — this includes those with severe claustrophobia (fear of enclosed spaces), a pacemaker implant, significantly reduced kidney function, severe obesity, pregnancy, or an allergy to the contrast dye used in the scan
  • People who do not wish to take part in the study
  • People whose physical or mental health makes participation in the study not possible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Consistency of LGE-MRI fibrosis and EAM low-voltage area

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov